Geneos Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Geneos Wealth Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$736	Hold
2024 Q3	$1.26K	Buy
2021 Q4	–	Sell
2021 Q3	$162K	Hold
2021 Q2	$177K	Sell
2021 Q1	$175K	Hold
2020 Q4	$163K	Buy